Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Other solid neoplasm 3

Conditions

Advanced Solid Tumors 481Solid Tumor 418Advanced Solid Tumor 409Unspecified Adult Solid Tumor, Protocol Specific 350Solid Tumors 322Mesothelioma, Malignant 281Mesothelioma 244Solid Tumor, Adult 113Carcinoma, Non-Small-Cell Lung 109Retinoblastoma 81Ovarian Neoplasms 65Lung Neoplasms 61Melanoma 56Sarcoma 52Stomach Neoplasms 50Carcinoma, Renal Cell 49Colorectal Neoplasms 46Small Cell Lung Carcinoma 45Pancreatic Neoplasms 45Esophageal Neoplasms 45Neoplasms 43Uterine Cervical Neoplasms 41Breast Neoplasms 38Advanced or Metastatic Solid Tumors 35Hematopoietic and Lymphatic System Neoplasm 34Neoplasm Metastasis 33Squamous Cell Carcinoma of Head and Neck 32Advanced Malignant Solid Tumors 31Solid Tumours 30Triple Negative Breast Neoplasms 29

Interventions

pazopanib 1Surveys and Questionnaires 1Sugars 1Everolimus 1Erlotinib Hydrochloride 1Asian ginseng 110-propargyl-10-deazaaminopterin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Advanced Cancers × Other solid neoplasm × Clear all
NCT01375114 2026-05-04

The Effects of Ginseng on Cancer-Related Fatigue

M.D. Anderson Cancer Center

Phase 1/2 Active not recruiting
165 enrolled 14 charts
Other solid neoplasm

Advanced Cancers

NCT01430572 2023-06-06

Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients

M.D. Anderson Cancer Center

Phase 1 Completed
62 enrolled
Other solid neoplasm

Advanced Cancers

NCT01532011 2016-07-04

Erlotinib in Combination With Pralatrexate in Advanced Malignancies

M.D. Anderson Cancer Center

Phase 1 Completed
72 enrolled
Other solid neoplasm

Advanced Cancers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡